BFS
BSX icon

Bradley Foster & Sargent’s Boston Scientific BSX Stock Holding History

Bradley Foster & Sargent’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Sell
69,510
-557,960
-89% -$30.3M 0.04% 198
2026
Q1 		$39.4M Buy
627,470
+134,550
+27% +$10.8M 0.61% 44
2025
Q4 		$47M Buy
492,920
+39,056
+9% +$3.83M 0.69% 40
2025
Q3 		$44.3M Sell
453,864
-100,560
-18% -$10.4M 0.65% 43
2025
Q2 		$59.6M Sell
554,424
-8,670
-2% -$877K 0.93% 30
2025
Q1 		$56.8M Sell
563,094
-15,843
-3% -$1.6M 0.97% 31
2024
Q4 		$51.7M Sell
578,937
-7,271
-1% -$640K 0.87% 31
2024
Q3 		$49.1M Sell
586,208
-82,188
-12% -$6.48M 0.82% 34
2024
Q2 		$51.5M Sell
668,396
-4,234
-0.6% -$310K 0.93% 33
2024
Q1 		$46.1M Sell
672,630
-2,366
-0.4% -$152K 0.83% 37
2023
Q4 		$39M Buy
674,996
+15,718
+2% +$839K 0.76% 41
2023
Q3 		$35.7M Hold
659,278
– – 0.75% 41
2023
Q2 		$35.7M Sell
659,278
-183,886
-22% -$9.6M 0.75% 41
2023
Q1 		$42.2M Buy
843,164
+4,742
+0.6% +$223K 1.01% 30
2022
Q4 		$38.8M Buy
838,422
+2,549
+0.3% +$110K 0.97% 33
2022
Q3 		$32.4M Buy
835,873
+5,178
+0.6% +$208K 0.9% 35
2022
Q2 		$31M Sell
830,695
-8,519
-1% -$347K 0.8% 42
2022
Q1 		$37.2M Buy
+839,214
New +$36.4M 0.79% 39

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bradley Foster & Sargent's BSX Position: Q2 2026 in Review

Bradley Foster & Sargent reduced its Boston Scientific (BSX) stake by 89% in Q2 2026, selling an estimated $30.3M and leaving 69,510 shares worth $2.97M. The position accounts for 0.04% of the portfolio, ranked #198.

Bradley Foster & Sargent first reported a position in BSX in Q1 2022 and has held it in 18 quarters since. The position peaked at $59.6M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bradley Foster & Sargent held 69,510 shares of Boston Scientific worth $2.97M as of Q2 2026.
  • Bradley Foster & Sargent sold 557,960 Boston Scientific shares in Q2 2026, an estimated $30.3M.
  • Boston Scientific made up 0.04% of Bradley Foster & Sargent's portfolio in Q2 2026, its #198 holding.
  • Bradley Foster & Sargent first reported a position in Boston Scientific in Q1 2022 and has held it in 18 quarters since.
  • Bradley Foster & Sargent's Boston Scientific position peaked at $59.6M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.